Trials / Completed
CompletedNCT03830567
Pharmacists Expand Access to Reproductive heaLthcare
Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 471 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 51 Years
- Healthy volunteers
- Accepted
Summary
Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.
Detailed description
Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription. This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmacist prescription | Pharmacist prescribed hormonal contraception (initiation or continuation). |
| OTHER | Clinician prescription | Clinician prescribed hormonal contraception (initiation or continuation). |
Timeline
- Start date
- 2019-01-27
- Primary completion
- 2021-02-02
- Completion
- 2022-02-28
- First posted
- 2019-02-05
- Last updated
- 2024-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03830567. Inclusion in this directory is not an endorsement.